Search Results - "Hong, Dongzhe"
-
1
Treatment preference among patients with spinal muscular atrophy (SMA): a discrete choice experiment
Published in Orphanet journal of rare diseases (20-01-2021)“…To examine patient/caregiver preference for key attributes of treatments for spinal muscular atrophy (SMA). In the rapidly evolving SMA treatment landscape, it…”
Get full text
Journal Article -
2
The Impact of Reimbursement for Non–Face-to-Face Chronic Care Management on Comprehensive Metabolic Biomarkers Among Multimorbid Patients With Type 2 Diabetes
Published in Medical care (01-03-2023)“…We evaluated the impact of reimbursement for non-face-to-face chronic care management (NFFCCM) on comprehensive metabolic risk factors among multimorbid…”
Get full text
Journal Article -
3
Correction to: Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review
Published in PharmacoEconomics (01-12-2019)“…CORE diabetes model was used throughout the article for consistency…”
Get full text
Journal Article -
4
Enhancing Health Care Affordability: Strategies for Accelerating Biosimilar Uptake
Published in Arthritis & rheumatology (Hoboken, N.J.) (14-10-2024)Get full text
Journal Article -
5
Biosimilar Uptake In The US: Patient And Prescriber Factors: Article examines biosimilar uptake in the US
Published in Health Affairs (01-08-2024)Get full text
Journal Article -
6
Biosimilar Uptake In The US: Patient And Prescriber Factors
Published in Health affairs (Millwood, Va.) (01-08-2024)“…Among 196,766 commercially insured and Medicare Advantage patients who newly initiated biologic drugs with available biosimilar versions, biosimilar initiation…”
Get full text
Journal Article -
7
Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review
Published in PharmacoEconomics (01-06-2019)“…Objective This study aimed to systematically review cost-effectiveness studies of newer antidiabetic medications. Methods The PubMed/MEDLINE, EMBASE, CINAHL…”
Get full text
Journal Article -
8
Effects of Non-Face-to-Face Chronic Care Management on Service Utilization and Outcomes Among US Medicare Beneficiaries with Diabetes
Published in Journal of general internal medicine : JGIM (01-08-2024)“…Background Type 2 diabetes mellitus (T2DM) results in heavy economic and disease burdens in Louisiana. The Centers for Medicare and Medicaid Services has…”
Get full text
Journal Article -
9
Addressing Regional Differences in Diabetes Progression: Global Calibration for Diabetes Simulation Model
Published in Value in health (01-12-2019)“…To develop a practical solution for modeling diabetes progression and account for the variations in risks of diabetes complications in different regions of the…”
Get full text
Journal Article -
10
Preference of Treatment Characteristics Among Patients with Spinal Muscular Atrophy (SMA): A Discrete Choice Experiment (192)
Published in Neurology (14-04-2020)“…Abstract only…”
Get full text
Journal Article -
11
-
12
The Impact of Reimbursement for Non-Face-to-Face Chronic Care Management on Health Utilization Among Patients With Type 2 Diabetes in Louisiana
Published in Value in health (01-05-2023)“…We evaluated the impact of reimbursement for non-face-to-face chronic care management (NFFCCM) on healthcare utilization among Medicare beneficiaries with type…”
Get full text
Journal Article -
13
Does the Encounter Type Matter When Defining Diabetes Complications in Electronic Health Records?
Published in Medical care (01-06-2020)“…BACKGROUND:Electronic health records (EHRs) and claims records are widely used in defining type 2 diabetes mellitus (T2DM) complications across different types…”
Get full text
Journal Article -
14
Correction to: Cost Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors: A Systematic Review
Published in PharmacoEconomics (01-12-2019)“…CORE diabetes model was used throughout the article for consistency…”
Get full text
Journal Article -
15
Characteristics of Patients Receiving Novel Muscular Dystrophy Drugs in Trials vs Routine Care
Published in JAMA network open (24-01-2024)“…The US Food and Drug Administration approved eteplirsen for Duchenne muscular dystrophy (DMD) in 2016 based on a controversial pivotal study that demonstrated…”
Get full text
Journal Article -
16
Cost Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors: A Systematic Review
Published in PharmacoEconomics (01-06-2019)“…Objective This study aimed to systematically review cost-effectiveness studies of newer antidiabetic medications. Methods The PubMed/MEDLINE, EMBASE, CINAHL…”
Get full text
Journal Article -
17
-
18
Electronic Medical Record Risk Modeling of Cardiovascular Outcomes Among Patients with Type 2 Diabetes
Published in Diabetes therapy (01-07-2021)“…Introduction Increased utilization of electronic health records (EHR) has enriched databases for creating risk models. We used machine learning techniques to…”
Get full text
Journal Article -
19
42-LB: Factors Associated with Use of Diabetes Self-Management Education and Support Programs in Newly Diagnosed Type 2 Diabetes Patients in Louisiana
Published in Diabetes (New York, N.Y.) (01-06-2020)“…Background: Prevalence of and factors associated with use of diabetes self-management education and support (DSME/S) programs in newly diagnosed type 2…”
Get full text
Journal Article -
20
Patient-specific factors associated with use of diabetes self-management education and support programs in Louisiana
Published in BMJ open diabetes research & care (01-12-2021)“…IntroductionThe prevalence of diabetes self-management education and support (DSME/S) use among patients with newly diagnosed type 2 diabetes mellitus (T2DM)…”
Get full text
Journal Article